Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Next Generation Internet ETF (ARKW) vs Johnson & Johnson (JNJ) Price & Performance

ARK Next Generation Internet ETF
Johnson & Johnson

Price performance

Price movement over the last 24 hours

Key statistics

ARK Next Generation Internet ETF vs Johnson & Johnson — how do they compare? ARK Next Generation Internet ETF trades at $147, while Johnson & Johnson trades at $258.58 (market cap $618.61B). The key difference: Johnson & Johnson pays a 2.09% dividend while ARK Next Generation Internet ETF pays none, and Johnson & Johnson is trading nearer its 52-week high, ARK Next Generation Internet ETF nearer its low. Which is the better fit depends on your goals.

ARKWJNJ
Sector
Sector/ThematicHealth
52-Week High
$182.20$267.24
52-Week Low
$114.45$155.17
Market Cap
$618.61B
Volume
6,156,228
Enterprise Value
$651.54B
Dividend Yield
2.09%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Next Generation Internet ETF

ARKW trades at $148.42, down 0.75% with a bullish technical signal from moving averages. The ETF shows neutral momentum oscillators with RSI at 52.51 suggesting balanced buying pressure. Support levels are established at $144 and $142, while resistance sits at $147 and $148. Recent news highlights Cathie Wood's continued focus on innovative technology investments through her ETF strategies.

The ETF's exposure to disruptive innovation themes presents growth potential amid technology sector momentum. Key risks include concentration in high-growth tech stocks and market volatility sensitivity. Institutional interest remains strong given ARK Invest's track record in identifying transformative technologies.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $256.98, down 0.82% today, with a bullish technical signal from moving averages and a consensus analyst price target of $268.50. The company reported strong Q1 2026 EPS of $2.70, beating expectations, and maintains robust profitability with a net income margin of 21.83%. Recent news highlights dividend growth strategies and comparisons with peers like AbbVie, while cash flow trends show operational strength despite negative net cash flow in 2025.

JNJ presents a stable investment opportunity with consistent earnings beats and a solid dividend, but faces risks from rising debt levels and competitive pressures. The stock's current valuation metrics, including a P/E of 29.78, suggest it is fairly valued with moderate upside potential based on analyst targets. Investors should weigh the company's strong fundamentals against macroeconomic and sector-specific headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Next Generation Internet ETF

ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.

Read more on ARKW

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ